↓ Skip to main content

Diagnosis Confirmation Model: A Value-Based Pricing Model for Inpatient Novel Antibiotics

Overview of attention for article published in The Journal of Law, Medicine & Ethics, January 2021
Altmetric Badge

Mentioned by

twitter
4 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Diagnosis Confirmation Model: A Value-Based Pricing Model for Inpatient Novel Antibiotics
Published in
The Journal of Law, Medicine & Ethics, January 2021
DOI 10.1177/1073110518782917
Pubmed ID
Authors

Ka Lum, Taimur Bhatti, Silas Holland, Mark Guthrie, Stephanie Sassman

Abstract

The Diagnosis Confirmation Model (DCM) includes a dual-pricing mechanism designed to support value-based pricing of novel antibiotics while improving the alignment of financial incentives with their optimal use in patients at high risk of drug-resistant infections. DCM is a market-based model and complementary to delinked models. Policymakers interested in stimulating antibiotic innovation could consider tailoring the DCM to their reimbursement systems and incorporating it into the suite of incentives to improve the economics of antibiotics.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 23%
Researcher 5 14%
Student > Ph. D. Student 3 9%
Student > Doctoral Student 2 6%
Other 2 6%
Other 3 9%
Unknown 12 34%
Readers by discipline Count As %
Economics, Econometrics and Finance 5 14%
Medicine and Dentistry 4 11%
Nursing and Health Professions 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Agricultural and Biological Sciences 3 9%
Other 6 17%
Unknown 11 31%